top of page
it's where dermatology lives
by Cory Perla
Oct 2, 20191 min read
Study: Combination of Two Immunotherapies Brings Advanced Melanoma Survival Rate up to 50% for First
By combining two existing therapies, researchers found that they have been able to stop or reverse the progression of advanced melanoma.
by John Evans
Mar 22, 20193 min read
Calcipotriol/5-FU tx for AKs may reduce future SCC development
“This finding provides the first clinical proof-of-concept that an immunotherapy directed against premalignant tumors can prevent cancer,” s
by John Evans
Aug 31, 20182 min read
Anti-PD-1/bacteria-emulating agent combination for advanced melanoma
This particular combination has been especially gratifying because not only does the SD-101 therapy drug induce tumour shrinkage at the actu
by John Evans
Jun 22, 20182 min read
Older patients respond better to melanoma immunotherapy
“Our study shows that age is an important factor to consider when administering immunotherapy to melanoma patients,” said Ashani Weeraratna,
by John Evans
Jun 5, 20184 min read
DPCP an option for treatment of patients with melanoma
“This is a treatment that had been used fairly extensively, especially in Australia, and been published on and seemed to have a good success
by John Evans
Apr 13, 20182 min read
Macrophages impair PD-1 immunotherapy in melanoma
"Our study suggests that assessing the abundance of macrophages and the contextual presence of CD8 T-cells—for example by measuring gen
by John Evans
Feb 23, 20182 min read
Blocking demethylase may drive melanoma cells into dormancy
“We think the combined use of demethylase blockers and targeted immunotherapy might be extremely effective [for treating melanoma],” said st
Derm City
Jan 12, 20182 min read
Anti-PD-1/PD-L1 therapy effective for desmoplastic melanoma
“Our findings challenge the previous school of thought that immunotherapy would offer little benefit to patients with desmoplastic melanoma
Featured Posts
bottom of page